Company News: Pfizer invests in Boston-area hospitals, Centron takes on OraPharma

Share this article:

Making good on its global initiative to bolster science and academia, New York-based pharma giant Pfizer has announced plans to invest $100 million with Boston's Longwood Medical Area. The investment will be made over the next five years and includes the establishment of a resource space – to be called the Center for Therapeutic Innovation – which will create about 50 new jobs. The aim of the company's partnership with Boston-area hospitals and med schools is to shorten the gaps that occur in the R&D stages of drug development.

Medical communications agency Centron has announced an account win with oral health company OraPharma. The agency will oversee medical communications responsibilities for Arestin, a localized antibiotic used in periodontics. “We're very excited to be chosen to guide development and execution of medical communications for Arestin,” said Marcia McLaughlin, President & CEO of Centron, in a release. “Our staff is ready to join the OraPharma team and deliver the strategic excellence we strive for every day.”

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in Business Briefs

FDA lifts OncoMed partial hold

The FDA froze the clinical trial of anti-Fzd7 vantictumab in July over concern about "bone-related adverse events."

Research links estrogen and binge eating

Baylor College of Medicine researchers have found that an estrogen replacement suppressed binge-eating behavior among lab mice.

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.